Details for Patent: 5,543,150
✉ Email this page to a colleague
Summary for Patent: 5,543,150
Title: | Method of progesterone delivery and affect thereof |
Abstract: | The present invention teaches that relatively low levels of serum progesterone, 1 to 6 ng/ml, may be used to prevent endometrial cancer. The vaginal delivery of progesterone using a cross-linked polycarboxylic polymer produces this low serum progesterone level while also providing the full secretory transformation of the endometrium, indicating the efficacy of the progesterone. Such low levels of serum progesterone will decrease the risk of breast cancer experienced by women undergoing hormone replacement therapy ("HRT") and minimize the potential of other undesirable progesterone associated side effects. |
Inventor(s): | Bologna; William J. (New York, NY), Levine; Howard L. (Oceanside, NY) |
Assignee: | Columbia Laboratories, Inc. (Coconut Grove, FL) |
Application Number: | 08/122,371 |
Patent Claim Types: see list of patent claims | Use; Delivery; Device; |
Drugs Protected by US Patent 5,543,150
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,543,150
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 174796 | ⤷ Try a Trial | |||
Australia | 689133 | ⤷ Try a Trial | |||
Australia | 7726194 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |